A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
Clinical trial NCT04372186 · COMPLETED
Trial details
- NCT number
- NCT04372186
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2020-08-18
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.